+Follow
yolopororo
No personal profile
6
Follow
0
Followers
0
Topic
0
Badge
Posts
Hot
yolopororo
2021-07-16
cool!
FedEx to invest $100 million in Indian logistics firm Delhivery
yolopororo
2021-07-16
nice!
Drugmaker GSK plans $550 mln expansion of England R&D facility
yolopororo
2021-07-16
jdidnsn
yolopororo
2021-07-14
biugb
yolopororo
2021-07-13
hgthbkob
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4088951070418820","uuid":"4088951070418820","gmtCreate":1625852715360,"gmtModify":1625852715360,"name":"yolopororo","pinyin":"yolopororo","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":6,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":170826266,"gmtCreate":1626421618855,"gmtModify":1703759848125,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"cool!","listText":"cool!","text":"cool!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/170826266","repostId":"1135598731","repostType":4,"repost":{"id":"1135598731","pubTimestamp":1626421256,"share":"https://ttm.financial/m/news/1135598731?lang=&edition=fundamental","pubTime":"2021-07-16 15:40","market":"us","language":"en","title":"FedEx to invest $100 million in Indian logistics firm Delhivery","url":"https://stock-news.laohu8.com/highlight/detail?id=1135598731","media":"Reuters","summary":"BENGALURU (Reuters) - FedEx Corp will make a $100-million equity investment in Indian e-commerce log","content":"<p>BENGALURU (Reuters) - FedEx Corp will make a $100-million equity investment in Indian e-commerce logistics startup Delhivery as part of a long-term commercial agreement, the U.S. delivery firm said on Friday.</p>\n<p>SoftBank-backed Delhivery will sell FedEx Express' international products and services in India, as part of the deal, and also provide pick-up and delivery services across the country.</p>\n<p>FedEx will also transfer some of its assets from its India business to Delhivery, enabling broader access to the the Gurgaon-based startup's pan-India network.</p>\n<p>Don Colleran, chief executive officer of FedEx Express, shall also get a board seat at Delhivery.</p>\n<p>Several Indian startups have spelt out plans to go public to cash in on liquidity by foreign funds. According to media reports, the startup which is eyeing a market debut as early as the fourth quarter is weighing a valuation of $4 billion.</p>\n<p>SoftBank-backed Indian digital payments startup Paytm has filed for an initial public offering, the latest in a lineup of unicorns that are planning to to go public, making India one of the hottest IPO markets in 2021. Food delivery startup Zomato's IPO subscription opened earlier this week and is awaiting listing.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FedEx to invest $100 million in Indian logistics firm Delhivery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFedEx to invest $100 million in Indian logistics firm Delhivery\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 15:40 GMT+8 <a href=https://finance.yahoo.com/news/fedex-invest-100-million-indian-071720778.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BENGALURU (Reuters) - FedEx Corp will make a $100-million equity investment in Indian e-commerce logistics startup Delhivery as part of a long-term commercial agreement, the U.S. delivery firm said on...</p>\n\n<a href=\"https://finance.yahoo.com/news/fedex-invest-100-million-indian-071720778.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FDX":"联邦快递"},"source_url":"https://finance.yahoo.com/news/fedex-invest-100-million-indian-071720778.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135598731","content_text":"BENGALURU (Reuters) - FedEx Corp will make a $100-million equity investment in Indian e-commerce logistics startup Delhivery as part of a long-term commercial agreement, the U.S. delivery firm said on Friday.\nSoftBank-backed Delhivery will sell FedEx Express' international products and services in India, as part of the deal, and also provide pick-up and delivery services across the country.\nFedEx will also transfer some of its assets from its India business to Delhivery, enabling broader access to the the Gurgaon-based startup's pan-India network.\nDon Colleran, chief executive officer of FedEx Express, shall also get a board seat at Delhivery.\nSeveral Indian startups have spelt out plans to go public to cash in on liquidity by foreign funds. According to media reports, the startup which is eyeing a market debut as early as the fourth quarter is weighing a valuation of $4 billion.\nSoftBank-backed Indian digital payments startup Paytm has filed for an initial public offering, the latest in a lineup of unicorns that are planning to to go public, making India one of the hottest IPO markets in 2021. Food delivery startup Zomato's IPO subscription opened earlier this week and is awaiting listing.","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170828277,"gmtCreate":1626421555899,"gmtModify":1703759846982,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"nice!","listText":"nice!","text":"nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/170828277","repostId":"2151508331","repostType":4,"repost":{"id":"2151508331","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626420022,"share":"https://ttm.financial/m/news/2151508331?lang=&edition=fundamental","pubTime":"2021-07-16 15:20","market":"us","language":"en","title":"Drugmaker GSK plans $550 mln expansion of England R&D facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2151508331","media":"Reuters","summary":"July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences","content":"<p>July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences campus within its R&D site in Stevenage, England, raising up to 400 million pounds ($552.76 million) by selling some land at the facility.</p>\n<p>The London-listed drugmaker said it expects to select a private-sector developer later this year and sell 33 acres of the 92-acre site. Work on the project, backed by the UK government, is expected to begin in 2022.</p>\n<p>GSK, locking horns with activist investor Elliott, is preparing for a planned spin-off of its consumer healthcare venture and focus on its prescription drugs and vaccines business, with heavy investments to develop a new line of products.</p>\n<p>\"Our goal is for Stevenage to emerge as the top destination for medical and scientific research by the end of the decade,\" said GSK senior executive Tony Wood.</p>\n<p>GSK hopes to create up to 5,000 jobs in the next five to 10 years with the addition of the new campus.</p>\n<p>Stevenage is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of GSK's two global R&D hubs and houses the UK's largest cell and gene therapy cluster.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Drugmaker GSK plans $550 mln expansion of England R&D facility</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDrugmaker GSK plans $550 mln expansion of England R&D facility\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-16 15:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences campus within its R&D site in Stevenage, England, raising up to 400 million pounds ($552.76 million) by selling some land at the facility.</p>\n<p>The London-listed drugmaker said it expects to select a private-sector developer later this year and sell 33 acres of the 92-acre site. Work on the project, backed by the UK government, is expected to begin in 2022.</p>\n<p>GSK, locking horns with activist investor Elliott, is preparing for a planned spin-off of its consumer healthcare venture and focus on its prescription drugs and vaccines business, with heavy investments to develop a new line of products.</p>\n<p>\"Our goal is for Stevenage to emerge as the top destination for medical and scientific research by the end of the decade,\" said GSK senior executive Tony Wood.</p>\n<p>GSK hopes to create up to 5,000 jobs in the next five to 10 years with the addition of the new campus.</p>\n<p>Stevenage is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of GSK's two global R&D hubs and houses the UK's largest cell and gene therapy cluster.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSK":"葛兰素史克"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151508331","content_text":"July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences campus within its R&D site in Stevenage, England, raising up to 400 million pounds ($552.76 million) by selling some land at the facility.\nThe London-listed drugmaker said it expects to select a private-sector developer later this year and sell 33 acres of the 92-acre site. Work on the project, backed by the UK government, is expected to begin in 2022.\nGSK, locking horns with activist investor Elliott, is preparing for a planned spin-off of its consumer healthcare venture and focus on its prescription drugs and vaccines business, with heavy investments to develop a new line of products.\n\"Our goal is for Stevenage to emerge as the top destination for medical and scientific research by the end of the decade,\" said GSK senior executive Tony Wood.\nGSK hopes to create up to 5,000 jobs in the next five to 10 years with the addition of the new campus.\nStevenage is one of GSK's two global R&D hubs and houses the UK's largest cell and gene therapy cluster.","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170821302,"gmtCreate":1626421498706,"gmtModify":1703759844368,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"jdidnsn","listText":"jdidnsn","text":"jdidnsn","images":[{"img":"https://static.tigerbbs.com/fb26b4d096d8fd6591cd0e96ca407037","width":"1125","height":"1826"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/170821302","isVote":1,"tweetType":1,"viewCount":173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":144863347,"gmtCreate":1626275476089,"gmtModify":1703756985674,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"biugb","listText":"biugb","text":"biugb","images":[{"img":"https://static.tigerbbs.com/8367cbe2590465b61729e330067a2a25","width":"1125","height":"1826"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/144863347","isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":145937537,"gmtCreate":1626185735229,"gmtModify":1703755107333,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"hgthbkob ","listText":"hgthbkob ","text":"hgthbkob","images":[{"img":"https://static.tigerbbs.com/6c5db8d7e62f44b893d9b05c22677dba","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/145937537","isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":170826266,"gmtCreate":1626421618855,"gmtModify":1703759848125,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"cool!","listText":"cool!","text":"cool!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/170826266","repostId":"1135598731","repostType":4,"repost":{"id":"1135598731","pubTimestamp":1626421256,"share":"https://ttm.financial/m/news/1135598731?lang=&edition=fundamental","pubTime":"2021-07-16 15:40","market":"us","language":"en","title":"FedEx to invest $100 million in Indian logistics firm Delhivery","url":"https://stock-news.laohu8.com/highlight/detail?id=1135598731","media":"Reuters","summary":"BENGALURU (Reuters) - FedEx Corp will make a $100-million equity investment in Indian e-commerce log","content":"<p>BENGALURU (Reuters) - FedEx Corp will make a $100-million equity investment in Indian e-commerce logistics startup Delhivery as part of a long-term commercial agreement, the U.S. delivery firm said on Friday.</p>\n<p>SoftBank-backed Delhivery will sell FedEx Express' international products and services in India, as part of the deal, and also provide pick-up and delivery services across the country.</p>\n<p>FedEx will also transfer some of its assets from its India business to Delhivery, enabling broader access to the the Gurgaon-based startup's pan-India network.</p>\n<p>Don Colleran, chief executive officer of FedEx Express, shall also get a board seat at Delhivery.</p>\n<p>Several Indian startups have spelt out plans to go public to cash in on liquidity by foreign funds. According to media reports, the startup which is eyeing a market debut as early as the fourth quarter is weighing a valuation of $4 billion.</p>\n<p>SoftBank-backed Indian digital payments startup Paytm has filed for an initial public offering, the latest in a lineup of unicorns that are planning to to go public, making India one of the hottest IPO markets in 2021. Food delivery startup Zomato's IPO subscription opened earlier this week and is awaiting listing.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FedEx to invest $100 million in Indian logistics firm Delhivery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFedEx to invest $100 million in Indian logistics firm Delhivery\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 15:40 GMT+8 <a href=https://finance.yahoo.com/news/fedex-invest-100-million-indian-071720778.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BENGALURU (Reuters) - FedEx Corp will make a $100-million equity investment in Indian e-commerce logistics startup Delhivery as part of a long-term commercial agreement, the U.S. delivery firm said on...</p>\n\n<a href=\"https://finance.yahoo.com/news/fedex-invest-100-million-indian-071720778.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FDX":"联邦快递"},"source_url":"https://finance.yahoo.com/news/fedex-invest-100-million-indian-071720778.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135598731","content_text":"BENGALURU (Reuters) - FedEx Corp will make a $100-million equity investment in Indian e-commerce logistics startup Delhivery as part of a long-term commercial agreement, the U.S. delivery firm said on Friday.\nSoftBank-backed Delhivery will sell FedEx Express' international products and services in India, as part of the deal, and also provide pick-up and delivery services across the country.\nFedEx will also transfer some of its assets from its India business to Delhivery, enabling broader access to the the Gurgaon-based startup's pan-India network.\nDon Colleran, chief executive officer of FedEx Express, shall also get a board seat at Delhivery.\nSeveral Indian startups have spelt out plans to go public to cash in on liquidity by foreign funds. According to media reports, the startup which is eyeing a market debut as early as the fourth quarter is weighing a valuation of $4 billion.\nSoftBank-backed Indian digital payments startup Paytm has filed for an initial public offering, the latest in a lineup of unicorns that are planning to to go public, making India one of the hottest IPO markets in 2021. Food delivery startup Zomato's IPO subscription opened earlier this week and is awaiting listing.","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170828277,"gmtCreate":1626421555899,"gmtModify":1703759846982,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"nice!","listText":"nice!","text":"nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/170828277","repostId":"2151508331","repostType":4,"repost":{"id":"2151508331","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626420022,"share":"https://ttm.financial/m/news/2151508331?lang=&edition=fundamental","pubTime":"2021-07-16 15:20","market":"us","language":"en","title":"Drugmaker GSK plans $550 mln expansion of England R&D facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2151508331","media":"Reuters","summary":"July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences","content":"<p>July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences campus within its R&D site in Stevenage, England, raising up to 400 million pounds ($552.76 million) by selling some land at the facility.</p>\n<p>The London-listed drugmaker said it expects to select a private-sector developer later this year and sell 33 acres of the 92-acre site. Work on the project, backed by the UK government, is expected to begin in 2022.</p>\n<p>GSK, locking horns with activist investor Elliott, is preparing for a planned spin-off of its consumer healthcare venture and focus on its prescription drugs and vaccines business, with heavy investments to develop a new line of products.</p>\n<p>\"Our goal is for Stevenage to emerge as the top destination for medical and scientific research by the end of the decade,\" said GSK senior executive Tony Wood.</p>\n<p>GSK hopes to create up to 5,000 jobs in the next five to 10 years with the addition of the new campus.</p>\n<p>Stevenage is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of GSK's two global R&D hubs and houses the UK's largest cell and gene therapy cluster.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Drugmaker GSK plans $550 mln expansion of England R&D facility</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDrugmaker GSK plans $550 mln expansion of England R&D facility\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-16 15:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences campus within its R&D site in Stevenage, England, raising up to 400 million pounds ($552.76 million) by selling some land at the facility.</p>\n<p>The London-listed drugmaker said it expects to select a private-sector developer later this year and sell 33 acres of the 92-acre site. Work on the project, backed by the UK government, is expected to begin in 2022.</p>\n<p>GSK, locking horns with activist investor Elliott, is preparing for a planned spin-off of its consumer healthcare venture and focus on its prescription drugs and vaccines business, with heavy investments to develop a new line of products.</p>\n<p>\"Our goal is for Stevenage to emerge as the top destination for medical and scientific research by the end of the decade,\" said GSK senior executive Tony Wood.</p>\n<p>GSK hopes to create up to 5,000 jobs in the next five to 10 years with the addition of the new campus.</p>\n<p>Stevenage is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of GSK's two global R&D hubs and houses the UK's largest cell and gene therapy cluster.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSK":"葛兰素史克"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151508331","content_text":"July 16 (Reuters) - Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences campus within its R&D site in Stevenage, England, raising up to 400 million pounds ($552.76 million) by selling some land at the facility.\nThe London-listed drugmaker said it expects to select a private-sector developer later this year and sell 33 acres of the 92-acre site. Work on the project, backed by the UK government, is expected to begin in 2022.\nGSK, locking horns with activist investor Elliott, is preparing for a planned spin-off of its consumer healthcare venture and focus on its prescription drugs and vaccines business, with heavy investments to develop a new line of products.\n\"Our goal is for Stevenage to emerge as the top destination for medical and scientific research by the end of the decade,\" said GSK senior executive Tony Wood.\nGSK hopes to create up to 5,000 jobs in the next five to 10 years with the addition of the new campus.\nStevenage is one of GSK's two global R&D hubs and houses the UK's largest cell and gene therapy cluster.","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170821302,"gmtCreate":1626421498706,"gmtModify":1703759844368,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"jdidnsn","listText":"jdidnsn","text":"jdidnsn","images":[{"img":"https://static.tigerbbs.com/fb26b4d096d8fd6591cd0e96ca407037","width":"1125","height":"1826"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/170821302","isVote":1,"tweetType":1,"viewCount":173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":144863347,"gmtCreate":1626275476089,"gmtModify":1703756985674,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"biugb","listText":"biugb","text":"biugb","images":[{"img":"https://static.tigerbbs.com/8367cbe2590465b61729e330067a2a25","width":"1125","height":"1826"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/144863347","isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":145937537,"gmtCreate":1626185735229,"gmtModify":1703755107333,"author":{"id":"4088951070418820","authorId":"4088951070418820","name":"yolopororo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088951070418820","authorIdStr":"4088951070418820"},"themes":[],"htmlText":"hgthbkob ","listText":"hgthbkob ","text":"hgthbkob","images":[{"img":"https://static.tigerbbs.com/6c5db8d7e62f44b893d9b05c22677dba","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/145937537","isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}
